Replies to post #248972 on Elite Pharmaceuticals Inc (ELTP)

[namtae]

For a proper understanding, I'll try to explain how things really work

See, LP has little to no interest in Elites valuation report. They probably didnt even glance at ir.

LP is not a value investor and makes its money in virtual risk less TRADES rarely having a long position for any appreciable amount of time..ditto a short position

They also make $$ gobbling up inducement shares which they sometimes are forced to hold long do to their restrictive nature, but they have a zero cost basis so...

Glad I could explain this so future mistakes are avoided

[snupoled]

NO2,

Did our present agreement with Lincoln end march 31?

looking for an update from our ceo as well as:

2-4 more anda filings
1-2 andas approved that have already been filed

generics revival

may sequestox results

humanwell utterances been a year since epic purchased

partnership/out right buy out.

well,

old snup was recently introduced by a young visitor to "the Walking
Dead" so back to it.

make it a great sunday elitesters.

SnupDAWGoled

[jour_trader]

Don't forget that dilution has caused an increase of 75% outstanding share count. Revenue is still paltry at best. Until the tech receives FDA approval future, revenues of much grander proportions are erroneous options to even consider.